PExA AB is a pharmaceutical company based in Göteborg that specializes in non-invasive distal airway liquid biopsy. The company focuses on developing innovative diagnostic solutions aimed at respiratory diseases, emphasizing early detection and monitoring of lung conditions. PExA AB employs a unique approach to analyzing airway samples, which is designed to enhance the understanding and management of respiratory health.
In addition to its diagnostic services, PExA AB is committed to advancing research in respiratory health. The company engages in activities such as a guaranteed preferential share issue to secure funding for its initiatives. PExA AB also provides a user-friendly platform tailored for healthcare professionals, which facilitates the use of its diagnostic tools. The organization aims to improve patient outcomes through the application of cutting-edge technology and regularly updates stakeholders on news and advancements in the field. Customer support is available for inquiries and assistance related to their services.